Cognito Therapeutics publishes OVERTURE Alzheimer's study results, suggesting Spectris headset-based therapy is safe and may benefit patients.
Cognito Therapeutics publishes OVERTURE Alzheimer's study results in Frontiers in Neurology. The randomized, double-blind, sham-controlled trial investigates Spectris, a headset-based therapy designed to evoke gamma frequency oscillations for patients with mild to moderate Alzheimer's disease. The six-month study at 5 US clinical trial sites suggests the treatment is safe and may benefit Alzheimer's patients.
March 06, 2024
3 Articles